Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-20-000046
Filing Date
2020-04-24
Accepted
2020-04-24 16:09:39
Documents
4
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxynotice2020.htm DEFA14A 18482
2 a2020proxynotice1of2.jpg GRAPHIC 331418
3 a2020proxynotice2of2.jpg GRAPHIC 270228
4 ligandlogo41719a03.jpg GRAPHIC 12141
  Complete submission text file 0000886163-20-000046.txt   848799
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 20815039
SIC: 2834 Pharmaceutical Preparations